AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program Read more
CANbridge and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics Read more
Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research Collaboration Read more